Company Filing History:
Years Active: 2010
Title: Mark D Yeager: Innovator in Polypeptide Research
Introduction
Mark D Yeager is a notable inventor based in Saddle River, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides. His work has implications for immunology and therapeutic applications.
Latest Patents
Mark D Yeager holds 1 patent. His patent features polypeptides comprising an amino acid sequence structurally related to SEQ ID NO: 1 or a fragment thereof. The invention includes AhpC-AhpF compositions and their uses. Notably, SEQ ID NO: 1 has a full-length AhpC sequence. A derivative of SEQ ID NO: 1, which contains an amino His-tag and three additional carboxyl amino acids, was found to produce a protective immune response.
Career Highlights
Mark D Yeager is associated with Merck Sharp & Dohme Corporation, a leading company in the pharmaceutical industry. His work at Merck has allowed him to focus on innovative research that contributes to advancements in health and medicine.
Collaborations
Throughout his career, Mark has collaborated with esteemed colleagues, including Rosemarie Kelly and Loren D Schultz. These collaborations have fostered a productive environment for research and development.
Conclusion
Mark D Yeager's contributions to polypeptide research exemplify the impact of innovation in biotechnology. His work continues to influence the field and holds promise for future advancements in immunology.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.